Glenview Capital Management Buys Lyft Inc, Boston Scientific Corp, Anthem Inc, Sells ViacomCBS Inc, Hologic Inc, HCA Healthcare Inc

• New Purchases: ANTM, NSC, DD, APTV, NSP, GPN, UNP, ARMK, DNB, AMZN, FB,
• Added Positions: LYFT, BSX, GOOGL, BAX, FISV, HUM, BHC, ESI, BKD, AMGN, PEAK, MYGN, CAR, WELL, EXPE, VVI, UHS, ABC, FMC,
• Reduced Positions: VIAC, HOLX, HCA, THC, LH, TAK, MTOR, MAR, MCK, IQV, URI, CTVA, CI, DGX, MSFT, NUAN, MOH, DVA, ENDP, MIK,
• Sold Out: EBAY, BHVN,

For the details of Larry Robbins's stock buys and sells, go to https://www.gurufocus.com/guru/larry+robbins/current-portfolio/portfolio

1. Tenet Healthcare Corp (THC) - 18,258,810 shares, 16.72% of the total portfolio. Shares reduced by 7.6%
2. Bausch Health Companies Inc (BHC) - 16,434,019 shares, 7.84% of the total portfolio. Shares added by 9.87%
3. Takeda Pharmaceutical Co Ltd (TAK) - 15,260,512 shares, 6.37% of the total portfolio. Shares reduced by 9.1%
4. DXC Technology Co (DXC) - 10,149,059 shares, 5.99% of the total portfolio. Shares reduced by 0.68%
5. Cigna Corp (CI) - 1,255,021 shares, 5.99% of the total portfolio. Shares reduced by 4.2%

Glenview Capital Management initiated holding in Anthem Inc. The purchase prices were between $272.8 and $333.15, with an estimated average price of $307.47. The stock is now traded at around $360.870000. The impact to a portfolio due to this purchase was 1.36%. The holding were 184,461 shares as of 2020-12-31.

Glenview Capital Management initiated holding in Norfolk Southern Corp. The purchase prices were between $198.11 and $246.77, with an estimated average price of $227.77. The stock is now traded at around $264.310000. The impact to a portfolio due to this purchase was 0.52%. The holding were 94,933 shares as of 2020-12-31.

Glenview Capital Management initiated holding in DuPont de Nemours Inc. The purchase prices were between $54.77 and $71.33, with an estimated average price of $62.69. The stock is now traded at around $76.680000. The impact to a portfolio due to this purchase was 0.42%. The holding were 258,003 shares as of 2020-12-31.

Glenview Capital Management initiated holding in Aptiv PLC. The purchase prices were between $93.56 and $130.79, with an estimated average price of $111.37. The stock is now traded at around $139.850000. The impact to a portfolio due to this purchase was 0.33%. The holding were 110,263 shares as of 2020-12-31.

Glenview Capital Management initiated holding in Global Payments Inc. The purchase prices were between $156.17 and $215.42, with an estimated average price of $186.6. The stock is now traded at around $201.670000. The impact to a portfolio due to this purchase was 0.3%. The holding were 60,143 shares as of 2020-12-31.

Glenview Capital Management initiated holding in Insperity Inc. The purchase prices were between $67.54 and $92.24, with an estimated average price of $82.36. The stock is now traded at around $82.080000. The impact to a portfolio due to this purchase was 0.3%. The holding were 159,983 shares as of 2020-12-31.

Glenview Capital Management added to a holding in Lyft Inc by 204.02%. The purchase prices were between $22.23 and $50.34, with an estimated average price of $36.53. The stock is now traded at around $60.970000. The impact to a portfolio due to this purchase was 1.56%. The holding were 2,064,179 shares as of 2020-12-31.

Glenview Capital Management added to a holding in Boston Scientific Corp by 158.64%. The purchase prices were between $33.15 and $41.97, with an estimated average price of $36. The stock is now traded at around $37.580000. The impact to a portfolio due to this purchase was 1.37%. The holding were 2,702,881 shares as of 2020-12-31.

Glenview Capital Management added to a holding in Alphabet Inc by 638.86%. The purchase prices were between $1451.02 and $1824.97, with an estimated average price of $1685.58. The stock is now traded at around $2032.530000. The impact to a portfolio due to this purchase was 0.99%. The holding were 28,409 shares as of 2020-12-31.

Glenview Capital Management added to a holding in Baxter International Inc by 321.37%. The purchase prices were between $75.39 and $82.36, with an estimated average price of $79.2. The stock is now traded at around $82.080000. The impact to a portfolio due to this purchase was 0.79%. The holding were 558,832 shares as of 2020-12-31.

Glenview Capital Management added to a holding in Fiserv Inc by 149.45%. The purchase prices were between $93.52 and $117.99, with an estimated average price of $107.82. The stock is now traded at around $123.250000. The impact to a portfolio due to this purchase was 0.75%. The holding were 483,726 shares as of 2020-12-31.

Glenview Capital Management added to a holding in Humana Inc by 91.94%. The purchase prices were between $388.23 and $452.01, with an estimated average price of $415.78. The stock is now traded at around $414.660000. The impact to a portfolio due to this purchase was 0.72%. The holding were 159,480 shares as of 2020-12-31.

Glenview Capital Management sold out a holding in eBay Inc. The sale prices were between $46.54 and $57.59, with an estimated average price of $51.03.

Glenview Capital Management sold out a holding in Biohaven Pharmaceutical Holding Co Ltd. The sale prices were between $65.07 and $98.24, with an estimated average price of $85.04.

Glenview Capital Management reduced to a holding in ViacomCBS Inc by 61%. The sale prices were between $27.13 and $37.26, with an estimated average price of $32.15. The stock is now traded at around $70.100000. The impact to a portfolio due to this sale was -1.84%. Glenview Capital Management still held 1,341,520 shares as of 2020-12-31.

Glenview Capital Management reduced to a holding in Hologic Inc by 44.53%. The sale prices were between $65.85 and $76.67, with an estimated average price of $70.66. The stock is now traded at around $71.980000. The impact to a portfolio due to this sale was -1.35%. Glenview Capital Management still held 804,442 shares as of 2020-12-31.

Glenview Capital Management reduced to a holding in HCA Healthcare Inc by 20.65%. The sale prices were between $123.94 and $165.86, with an estimated average price of $146.56. The stock is now traded at around $184.590000. The impact to a portfolio due to this sale was -1.32%. Glenview Capital Management still held 1,300,181 shares as of 2020-12-31.

Glenview Capital Management reduced to a holding in Laboratory Corp of America Holdings by 20.94%. The sale prices were between $187.99 and $214.42, with an estimated average price of $201.28. The stock is now traded at around $250.420000. The impact to a portfolio due to this sale was -0.86%. Glenview Capital Management still held 552,187 shares as of 2020-12-31.

Glenview Capital Management reduced to a holding in Meritor Inc by 28.77%. The sale prices were between $22.62 and $28.57, with an estimated average price of $26.5. The stock is now traded at around $27.870000. The impact to a portfolio due to this sale was -0.73%. Glenview Capital Management still held 2,757,332 shares as of 2020-12-31.

Glenview Capital Management reduced to a holding in Marriott International Inc by 47.77%. The sale prices were between $89.97 and $135.61, with an estimated average price of $114.55. The stock is now traded at around $143.280000. The impact to a portfolio due to this sale was -0.61%. Glenview Capital Management still held 228,619 shares as of 2020-12-31.